Vitamin Shoppe (VSI) Tops Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- S&P, Dow edge higher on Mideast deal hopes; SpaceX debut in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil falls to near two-month lows as Trump calls off threatened strikes on Iran
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Wall St set to gain on tech rebound, Middle East in focus
Piper Jaffray Cuts Price Target as Vitamin Shoppe (VSI) Guides Q1 Comps to Single Digits
February 24, 2016 9:54 AM ESTPiper Jaffray maintained a Neutral rating on Vitamin Shoppe (NYSE: VSI), and cut the price target to $30.00 (from $34.00), following the company's 4Q earnings report and guidance. Q1 comps were guided down to low single digits, likely not improving from the (0.9%) rate in Q4. The... More
